TORLEY HELEN (PRESIDENT AND CEO) sold 7.2% of their position (60K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.28M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+20K
Price / share
$18.41
Trade value
$368.20K
% of position
Common Stock
Shares
−900.00
Price / share
$98.96
Trade value
$89.06K
% of position
Common Stock
Shares
−500.00
Price / share
$100.46
Trade value
$50.23K
% of position
Common Stock
Shares
−2.10K
Price / share
$101.77
Trade value
$213.71K
% of position
Common Stock
Shares
−9K
Price / share
$102.55
Trade value
$922.98K
% of position
Common Stock
Shares
−7.50K
Price / share
$103.48
Trade value
$776.12K
% of position
Common Stock
Shares
+20K
Price / share
$18.41
Trade value
$368.20K
% of position
Common Stock
Shares
−5.70K
Price / share
$103.08
Trade value
$587.88K
% of position
Common Stock
Shares
−4.90K
Price / share
$104.11
Trade value
$509.83K
% of position
Common Stock
Shares
−9.40K
Price / share
$104.87
Trade value
$985.82K
% of position
Common Stock
Shares
+20K
Price / share
$18.41
Trade value
$368.20K
% of position
Common Stock
Shares
−7.20K
Price / share
$106.36
Trade value
$765.78K
% of position
Common Stock
Shares
−9.60K
Price / share
$107.22
Trade value
$1.03M
% of position
Common Stock
Shares
−3.20K
Price / share
$107.77
Trade value
$344.85K
% of position
Net shares
+0.00
Net value
-$5.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2026 | M · Option Exercise | +20K | $18.41 | $368.20K | 2.6% | 767.78K | 787.78K |
| Common Stock Direct | 8/17/2026 | S · Sale | −900.00 | $98.96 | $89.06K | 0.1% | 787.78K | 786.88K |
| Common Stock Direct | 8/17/2026 | S · Sale | −500.00 | $100.46 | $50.23K | 0.1% | 786.88K | 786.38K |
| Common Stock Direct | 8/17/2026 | S · Sale | −2.10K | $101.77 | $213.71K | 0.3% | 786.38K | 784.28K |
| Common Stock Direct | 8/17/2026 | S · Sale | −9K | $102.55 | $922.98K | 1.1% | 784.28K | 775.28K |
| Common Stock Direct | 8/17/2026 | S · Sale | −7.50K | $103.48 | $776.12K | 1.0% | 775.28K | 767.78K |
| Common Stock Direct | 8/18/2026 | M · Option Exercise | +20K | $18.41 | $368.20K | 2.6% | 767.78K | 787.78K |
| Common Stock Direct | 8/18/2026 | S · Sale | −5.70K | $103.08 | $587.88K | 0.7% | 787.78K | 782.08K |
| Common Stock Direct | 8/18/2026 | S · Sale | −4.90K | $104.11 | $509.83K | 0.6% | 782.08K | 777.18K |
| Common Stock Direct | 8/18/2026 | S · Sale | −9.40K | $104.87 | $985.82K | 1.2% | 777.18K | 767.78K |
| Common Stock Direct | 8/19/2026 | M · Option Exercise | +20K | $18.41 | $368.20K | 2.6% | 767.78K | 787.78K |
| Common Stock Direct | 8/19/2026 | S · Sale | −7.20K | $106.36 | $765.78K | 0.9% | 787.78K | 780.58K |
| Common Stock Direct | 8/19/2026 | S · Sale | −9.60K | $107.22 | $1.03M | 1.2% | 780.58K | 770.98K |
| Common Stock Direct | 8/19/2026 | S · Sale | −3.20K | $107.77 | $344.85K | 0.4% | 770.98K | 767.78K |
| Total | +0.00 | -$5.17M | ||||||
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
18.41
Held after
181.55K
Exercisable
—
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
18.41
Held after
161.55K
Exercisable
—
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
18.41
Held after
141.55K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock20K shares | 8/17/2026 | M · Option Exercise | −20K | 18.41 | — | 181.55K |
| Option to Purchase Common Stock Direct | Common Stock20K shares | 8/18/2026 | M · Option Exercise | −20K | 18.41 | — | 161.55K |
| Option to Purchase Common Stock Direct | Common Stock20K shares | 8/19/2026 | M · Option Exercise | −20K | 18.41 | — | 141.55K |